How Esketamine Works in the Brain

Key Takeaways: 

• Esketamine’s Unique Mechanism: Unlike traditional antidepressants, esketamine targets the brain’s glutamate system, promoting neuroplasticity and faster symptom relief for treatment-resistant depression.
• Supervised Treatment: Spravato (esketamine nasal spray) is FDA-approved and administered in clinics under strict monitoring to ensure safety and manage side effects like dissociation and sedation.
• Neuroplasticity and Mood Improvement: Esketamine helps “rewire” the brain by encouraging synapse growth, improving connectivity in mood-regulating brain circuits.
• Holistic Care is Essential: While esketamine offers rapid relief, maintaining progress requires a comprehensive care plan, including therapy and ongoing medication management.

Question: 

How does Esketamine work on the brain? 

Answer: 

Esketamine, a breakthrough treatment for treatment-resistant depression, works differently from traditional antidepressants by targeting the brain’s glutamate system. This approach promotes neuroplasticity, helping the brain repair damaged connections and providing faster symptom relief. Administered as Spravato, an FDA-approved nasal spray, treatment occurs in a clinical setting with close supervision to manage side effects like dissociation and sedation. While esketamine offers hope for those who haven’t found relief with other medications, it’s not a standalone solution. Sustained progress requires a holistic care plan, including therapy and medication management. For individuals with co-occurring substance use concerns, esketamine’s controlled administration reduces misuse risks, making it a viable option under professional guidance. If you’re exploring options for treatment-resistant depression, esketamine could be a game-changer as part of an integrated recovery plan.

For millions of people living with depression, the path to relief is often a waiting game. You take a pill, wait four to six weeks, and hope the fog lifts. If it doesn’t, you try another. This cycle is exhausting, especially for those with treatment-resistant depression (TRD).

If you are reading this, you might be looking for something different. You may have heard about esketamine (brand name Spravato), a treatment that works differently than the standard antidepressants you’ve tried before. Unlike traditional medications that build up slowly, esketamine has earned a reputation for working quickly—sometimes within hours or days.

But why does it work faster? Is it safe? And what exactly is it doing inside your brain?

This post explains the science behind esketamine, focusing on the glutamate system, neuroplasticity, and why this treatment requires careful medical supervision.

What Is Esketamine (and What Is Spravato)?

Before diving into brain chemistry, it is important to clarify what we are talking about.

Esketamine is a version of the anesthetic drug ketamine. Specifically, it is the “S-enantiomer” of ketamine. If you think of chemical molecules like hands, esketamine is essentially the “left hand” of the ketamine molecule. It is more potent than generic ketamine, allowing for lower doses.

Spravato is the brand name for the FDA-approved nasal spray formulation of esketamine. It is currently the only version approved specifically for adults with treatment-resistant depression or depressive symptoms with acute suicidal ideation or behavior. Because of its potency and potential risks, Spravato is only available through a restricted safety program called REMS (Risk Evaluation and Mitigation Strategy).

While scientists are still mapping out the exact antidepressant mechanism, leading research suggests it works by targeting glutamate signaling and brain plasticity.

Depression and the Brain: A Quick Primer

To understand how esketamine fixes the problem, we first need to look at what might be going wrong in the brain during depression.

The Brain Circuits Involved

Depression isn’t just about feeling sad; it is biologically linked to how different parts of your brain communicate. Chronic stress and depression are often associated with disrupted connectivity in the networks that regulate mood. Specifically, the connections between the prefrontal cortex (the thinking brain) and the limbic system (the emotional brain) can become weak or “withered.”

Monoamines vs. Glutamate

For decades, traditional antidepressants like SSRIs (Prozac, Zoloft) and SNRIs have focused on monoamines. These are neurotransmitters like serotonin, norepinephrine, and dopamine. The theory was that low levels of these chemicals caused depression.

However, esketamine takes a completely different lane. It targets the glutamate system. Glutamate is the most abundant excitatory neurotransmitter in the brain. If serotonin regulates your mood like a thermostat, glutamate is more like the electrical grid that powers the entire house.

Step-by-Step: How Esketamine Works in the Brain

This is the core of why esketamine is considered a breakthrough. It doesn’t just boost serotonin levels; it helps repair the “wiring” of the brain. Here is a simplified breakdown of the process.

Step 1: NMDA Receptor Antagonism

It starts with a receptor in your brain called the NMDA receptor. These receptors act like gates on your nerve cells. In people with chronic depression, these gates might be functioning in a way that dampens healthy brain signaling.

Esketamine acts as an NMDA receptor antagonist. This means it blocks these receptors. It’s like putting a key in a lock but not turning it, effectively temporarily blocking that specific pathway.

Step 2: Glutamate Surge and AMPA Signaling

When the NMDA receptors are blocked, the brain reacts in a surprising way. It triggers a release of glutamate. This surge of glutamate then looks for other places to go. Since the NMDA receptors are blocked, the glutamate binds to a different set of receptors called AMPA receptors.

You can think of AMPA receptors as the “go” buttons for your neurons. When they are activated, they increase communication between brain cells.

Step 3: Neuroplasticity and Synaptogenesis

This is the most exciting part for researchers. The activation of AMPA receptors sets off a chain reaction of protein production (often involving a protein called BDNF). This process encourages neuroplasticity.

Neuroplasticity is the brain’s ability to change and adapt. Esketamine appears to help the brain grow new synapses (connections between neurons)—a process called synaptogenesis. It essentially helps the brain “rewire” itself, restoring the connections that chronic stress and depression may have damaged.

Step 4: Fast Effects and Maintenance

Because this process involves a rapid release of glutamate and immediate signaling changes, patients often feel relief much faster than with oral antidepressants.

However, neuroplasticity is an opportunity, not a permanent fix. Think of esketamine as clearing a heavy snowfall off a path. It opens the way, but you still need to walk down it. Maintaining these positive changes typically requires a broader care plan, including therapy and medication management, to ensure the new connections remain strong.